J 2021

Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model

KRIPNEROVA, M., H.S. PARMAR, Jiří ŠÁNA, Alena KOPKOVÁ, Lenka RADOVÁ et. al.

Basic information

Original name

Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model

Authors

KRIPNEROVA, M., H.S. PARMAR, Jiří ŠÁNA (203 Czech Republic, belonging to the institution), Alena KOPKOVÁ (203 Czech Republic, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), S. SOPPER, K. BIERNACKI, J. JEDLICKA, M. KOHOUTOVA, J. KUNCOVA, J. PEYCHL, E. RUDOLF, M. CERVINKA, Z. HOUDEK, P. DVORAK, K. HOUFKOVA, M. PESTA, Z. TUMA, M. DOLEJSOVA, F. TICHANEK, V. BABUSKA, M. LEBA, Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution) and J. HATINA

Edition

Journal of Clinical Medicine, Basel, MDPI, 2021, 2077-0383

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.964

RIV identification code

RIV/00216224:14740/21:00119079

Organization unit

Central European Institute of Technology

UT WoS

000660208500001

Keywords in English

fibrosarcoma; progression series; invasiveness; transcriptome; Ccl8

Tags

International impact, Reviewed
Změněno: 15/10/2024 14:30, Ing. Martina Blahová

Abstract

V originále

Sarcomas are a heterogeneous group of mesenchymal tumours, with a great variability in their clinical behaviour. While our knowledge of sarcoma initiation has advanced rapidly in recent years, relatively little is known about mechanisms of sarcoma progression. JUN-murine fibrosarcoma progression series consists of four sarcoma cell lines, JUN-1, JUN-2, JUN-2fos-3, and JUN-3. JUN-1 and -2 were established from a single tumour initiated in a H2K/v-jun transgenic mouse, JUN-3 originates from a different tumour in the same animal, and JUN-2fos-3 results from a targeted in vitro transformation of the JUN-2 cell line. The JUN-1, -2, and -3 cell lines represent a linear progression from the least transformed JUN-2 to the most transformed JUN-3, with regard to all the transformation characteristics studied, while the JUN-2fos-3 cell line exhibits a unique transformation mode, with little deregulation of cell growth and proliferation, but pronounced motility and invasiveness. The invasive sarcoma sublines JUN-2fos-3 and JUN-3 show complex metabolic profiles, with activation of both mitochondrial oxidative phosphorylation and glycolysis and a significant increase in spared respiratory capacity. The specific transcriptomic profile of invasive sublines features very complex biological relationships across the identified genes and proteins, with accentuated autocrine control of motility and angiogenesis. Pharmacologic inhibition of one of the autocrine motility factors identified, Ccl8, significantly diminished both motility and invasiveness of the highly transformed fibrosarcoma cell. This progression series could be greatly valuable for deciphering crucial aspects of sarcoma progression and defining new prognostic markers and potential therapeutic targets.

Links

GA17-17636S, research and development project
Name: Identifikace nových prognostických markerů a terapeutických cílových molekul u sarkomu měkkých tkání
Investor: Czech Science Foundation
90132, large research infrastructures
Name: NCMG II